Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures and markets pharmaceutical, molecular diagnostics, and electronic products in India and internationally. The company is involved in the supply of pharmaceutical preparations, such as finished dosage forms and active pharmaceutical ingredients; manufacture of fermentation-based pharmaceutical products; and manufactur...
Ambalal Sarabhai Enterprises reported revenue of 1.95 billion INR for fiscal year 2025, up 12.9% from fiscal year 2024, and net income of 49.31 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 519.96 million INR, up 13.1% from a year before.
Figures from company filings; latest fiscal year ended March 31, 2025.
No profile data available.